TasP in Correctional Facilities

NACompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
HIVTuberculosis
Interventions
OTHER

Test and treat

All incarcerated individuals found to have HIV infection will be offered universal voluntary HIV counseling and testing (HCV) through routine care provided at the correctional facility followed by referral to the study for immediate (routine, non-study prescribed) ART, regardless of CD4 cell count. The ART regimen prescribed will be the standard first-line, fixed-dose combination efavirenz plus lamivudine/emtricitabine and tenofovir per Zambian national guidelines.

Trial Locations (1)

Unknown

Lusaka Central Corrections ART Clinic, Lusaka

All Listed Sponsors
collaborator

Department for International Development, United Kingdom

OTHER_GOV

lead

University of North Carolina, Chapel Hill

OTHER

NCT02946762 - TasP in Correctional Facilities | Biotech Hunter | Biotech Hunter